Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Jakarta - Delayed Quote IDR

PT Merck Tbk (MERK.JK)

Compare
3,460.00
+10.00
+(0.29%)
At close: February 21 at 3:07:55 PM GMT+7

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.
NameTitlePayExercisedYear Born
Ms. Evie Yulin President Director & Biopharma Director -- -- 1967
Mr. Bambang Nurcahyo Finance Director & Director -- -- 1970
Eduan Tjong Supply Chain & Operation Manager -- -- --
Miranda Andamsari Compliance Officer -- -- --
Taufiq Wibowo Head of Legal -- -- --
Ms. Melisa Sandrianti Corporate Secretary & Corporate Communications Manager -- -- 1978
Aquira Kurniawati Moeladi Human Resource Head -- -- --
Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat Plant Director & Independent Director -- -- 1972
Ms. Pachita Ramadhani Head of Internal Audit Unit & Sr Finance Manager -- -- 1980
Bundi Jannius Head of Site Pharma Tech -- -- --

PT Merck Tbk

Jl. TB Simatupang No. 8
Pasar Rebo
Jakarta Timur, 13760
Indonesia
62 21 2856 5600 https://www.merckgroup.com/id-id
Sector: 
Healthcare
Full Time Employees: 
376

Description

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.

Corporate Governance

PT Merck Tbk’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 7, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers